HRP931474A2 - Transdermal administration system containing acetylsalicylic acid for antithrombotic therapy and the prevention of canser - Google Patents

Transdermal administration system containing acetylsalicylic acid for antithrombotic therapy and the prevention of canser

Info

Publication number
HRP931474A2
HRP931474A2 HR931474A HRP931474A HRP931474A2 HR P931474 A2 HRP931474 A2 HR P931474A2 HR 931474 A HR931474 A HR 931474A HR P931474 A HRP931474 A HR P931474A HR P931474 A2 HRP931474 A2 HR P931474A2
Authority
HR
Croatia
Prior art keywords
canser
prevention
system containing
transdermal administration
acetylsalicylic acid
Prior art date
Application number
HR931474A
Other languages
English (en)
Inventor
Frank Becher
Thomas Kissel
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4241128A external-priority patent/DE4241128C2/de
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of HRP931474A2 publication Critical patent/HRP931474A2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HR931474A 1992-12-07 1993-12-03 Transdermal administration system containing acetylsalicylic acid for antithrombotic therapy and the prevention of canser HRP931474A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4241128A DE4241128C2 (de) 1991-12-20 1992-12-07 Verwendung eines transdermalen Verabreichungssystems, das als Wirkstoff Acetylsalicylsäure und/oder pharmazeutisch akzeptable Salze davon enthält

Publications (1)

Publication Number Publication Date
HRP931474A2 true HRP931474A2 (en) 1994-12-31

Family

ID=6474576

Family Applications (1)

Application Number Title Priority Date Filing Date
HR931474A HRP931474A2 (en) 1992-12-07 1993-12-03 Transdermal administration system containing acetylsalicylic acid for antithrombotic therapy and the prevention of canser

Country Status (14)

Country Link
EP (1) EP0671916A1 (de)
JP (1) JP3799502B2 (de)
AU (1) AU694410B2 (de)
CA (1) CA2150033A1 (de)
CZ (1) CZ149495A3 (de)
FI (1) FI120719B (de)
HR (1) HRP931474A2 (de)
HU (1) HUT75680A (de)
IL (1) IL107867A (de)
NO (1) NO952234D0 (de)
NZ (1) NZ258129A (de)
PL (1) PL174770B1 (de)
SK (1) SK75495A3 (de)
ZA (1) ZA939126B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1738623A (zh) * 2003-01-23 2006-02-22 夏尔控股公司 治疗血小板增多症的制剂和方法
EP1716854A4 (de) 2004-02-16 2010-01-20 Teikoku Seiyaku Kk Äusserlich anzuwendende zubereitung zur behandlung schmerzhafter hautwunden
US7910597B2 (en) 2006-11-28 2011-03-22 Shire Llc Substituted quinazolines
US8304420B2 (en) 2006-11-28 2012-11-06 Shire Llc Substituted quinazolines for reducing platelet count
JP6720257B2 (ja) * 2018-09-05 2020-07-08 テックフィールズ インコーポレイテッド 非常に速い皮膚及び膜浸透速度を有するｎｓａｉａプロドラッグ及びその新規医薬使用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2496459A1 (fr) * 1980-12-19 1982-06-25 Astier Laboratoires Docteur P Composition pharmaceutique sous forme d'un gel contenant de l'acide acetylsalicylique
IL68965A (en) * 1983-06-13 1987-02-27 Rafa Labor Ltd Topical pharmaceutical preparation comprising acetylsalicylic acid for the treatment of dermatological disorders
HRP921157A2 (en) * 1991-12-20 1994-10-31 Lohmann Therapie Syst Lts Transdermal system of applying acetilsalicilyc acid in antithrombosys therapy

Also Published As

Publication number Publication date
CA2150033A1 (en) 1994-06-23
FI952805A0 (fi) 1995-06-07
IL107867A0 (en) 1994-04-12
AU5563294A (en) 1994-07-04
NO952234L (no) 1995-06-06
NO952234D0 (no) 1995-06-06
PL309285A1 (en) 1995-10-02
NZ258129A (en) 1999-10-28
AU694410B2 (en) 1998-07-23
HU9501641D0 (en) 1995-08-28
EP0671916A1 (de) 1995-09-20
HUT75680A (en) 1997-05-28
SK75495A3 (en) 1996-05-08
ZA939126B (en) 1994-08-05
FI952805A (fi) 1995-06-07
FI120719B (fi) 2010-02-15
PL174770B1 (pl) 1998-09-30
JP3799502B2 (ja) 2006-07-19
CZ149495A3 (en) 1996-03-13
IL107867A (en) 1998-08-16
JPH08504198A (ja) 1996-05-07

Similar Documents

Publication Publication Date Title
EP0692975A4 (de) Verabreichung eines vaso-aktiven wirkstoffes und eines therapeutischen wirkstoffes
GB2184016B (en) Therapeutic device for the administration of medicaments
HU9303282D0 (en) Pharmaceutical preparations containing hialuronic acid and/or derivatives and/or fragments
EP0752885A4 (de) Therapeutischer inhibitor der vaskulären glatten muskelzellen
GB2205496B (en) Medicinal or therapeutic pack
HU9303283D0 (en) Pharmaceutical preparations containing hialuronic acid and/or derivatives and/or fragments
EP0428585A4 (en) Novel method of administering aspirin and dosage forms containing same
GB9226832D0 (en) Pharmaceutical preparations for the treatment of psoriasis
IL86302A0 (en) Pharmaceutical combination for the prophylaxis and therapy of malaria
AU1956092A (en) Pharmaceutical agent for treatment of withdrawal symptoms
ZA869694B (en) Azoniaspironortropanol esters and their pharmaceutical use
HRP931474A2 (en) Transdermal administration system containing acetylsalicylic acid for antithrombotic therapy and the prevention of canser
ZA891718B (en) Orally administered system for the controller release of active substances
EP0223254A3 (en) Preparations for the treatment and prevention of epithelial destruction
GB2162748B (en) Medicinal composition for the treatment or prevention of acne by oral administration
HU9402816D0 (en) Medicament for the treatment of airways inflammation and airways hyperresponsiveness
HUT74076A (en) Pharmaceutical preparation containing penciclorin for the treatment of post-therapeutic neuralgia
ZA931700B (en) Use of L-carnitine for treating carnitine-depleted HIV-seropositive patients
ZA948192B (en) Pharmaceutical formulation of aspirin and sallcylates
AU1778088A (en) Use of analgesic anti-inflammatory drugs in treating haemorrhoidal bleeding
ZA86774B (en) Method of analgesic treatment and pharmaceutical compositions
IL94737A0 (en) System for transdermal administration of medicaments
GB2266241B (en) Treatment of pastures
GB9413939D0 (en) Pharmaceutical composition for the treatment of chronic skin ulcers
IL97215A0 (en) Transdermal administration of medicaments

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20011203

Year of fee payment: 9

ODBI Application refused